근위축측삭경화증에서 Nuedexta (Dextromethorphan and Quinidine)의 연수기능 개선에 대한 증례
Improved Bulbar Function in Amyotrophic Lateral Sclerosis after Nuedexta (Dextromethorphan and Quinidine) Treatment
조희진, 박진모, 박진성,
소속 상세정보
조희진 ( Cho Hee-Jin )
칠곡경북대학교병원 신경과
박진모 ( Park Jin-Mo )
동국대학교 의과대학 신경과학교실
박진성 ( Park Jin-Sung )
경북대학교 의과대학 신경과학교실
Abstract
Nuedexta (dextromethorphan and quinidine) is an Food and Drug Administration approved medication for pseudobulbar affect. Interestingly, this drug was recently reported to improve speech, swallowing, and the ability to handle oral secretions along with emotional lability in amyotrophic lateral sclerosis (ALS) patients with bulbar symptoms. We report a Korean ALS patient whose bulbar function improved after administering Nuedexta for 6 months, extending therapeutic choice of approach in treating ALS patients.
키워드
Dextromethorphan; Quinidine; Amyotrophic lateral sclerosis
원문 및 링크아웃 정보
등재저널 정보